Molecule-pharmacophore superpositioning and pattern matching in computational drug design. 2008

Gerhard Wolber, and Thomas Seidel, and Fabian Bendix, and Thierry Langer
Inte:Ligand GmbH, Mariahilferstrasse 74B/11, 1070 Vienna, Austria. wolber@inteligand.com

Three-dimensional (3D) pharmacophore modeling is a technique for describing the interaction of a small molecule ligand with a macromolecular target. Since chemical features in a pharmacophore model are well known and highly transparent for medicinal chemists, these models are intuitively understandable and have been increasingly successful in computational drug discovery in the past few years. The performance and applicability of pharmacophore modeling depends on two main factors: the definition and placement of pharmacophoric features and the alignment techniques used to overlay 3D pharmacophore models and small molecules. An overview of key technologies and latest developments in the area of 3D pharmacophores is given and provides insight into different approaches as implemented by the 3D pharmacophore modeling packages like Catalyst, MOE, Phase and LigandScout.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D006860 Hydrogen Bonding A low-energy attractive force between hydrogen and another element. It plays a major role in determining the properties of water, proteins, and other compounds. Hydrogen Bonds,Bond, Hydrogen,Hydrogen Bond
D000465 Algorithms A procedure consisting of a sequence of algebraic formulas and/or logical steps to calculate or determine a given task. Algorithm
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D017076 Computer-Aided Design The use of computers for designing and/or manufacturing of anything, including drugs, surgical procedures, orthotics, and prosthetics. CAD-CAM,Computer-Aided Manufacturing,Computer-Assisted Design,Computer-Assisted Manufacturing,Computer Aided Design,Computer Aided Manufacturing,Computer Assisted Design,Computer Assisted Manufacturing,Computer-Aided Designs,Computer-Assisted Designs,Design, Computer-Aided,Design, Computer-Assisted,Designs, Computer-Aided,Designs, Computer-Assisted,Manufacturing, Computer-Aided,Manufacturing, Computer-Assisted

Related Publications

Gerhard Wolber, and Thomas Seidel, and Fabian Bendix, and Thierry Langer
January 2013, Biophysical journal,
Gerhard Wolber, and Thomas Seidel, and Fabian Bendix, and Thierry Langer
September 2011, Current computer-aided drug design,
Gerhard Wolber, and Thomas Seidel, and Fabian Bendix, and Thierry Langer
May 2022, Pharmaceuticals (Basel, Switzerland),
Gerhard Wolber, and Thomas Seidel, and Fabian Bendix, and Thierry Langer
July 2005, IDrugs : the investigational drugs journal,
Gerhard Wolber, and Thomas Seidel, and Fabian Bendix, and Thierry Langer
November 1999, Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti,
Gerhard Wolber, and Thomas Seidel, and Fabian Bendix, and Thierry Langer
April 2008, Journal of chemical information and modeling,
Gerhard Wolber, and Thomas Seidel, and Fabian Bendix, and Thierry Langer
January 2023, Frontiers in bioengineering and biotechnology,
Gerhard Wolber, and Thomas Seidel, and Fabian Bendix, and Thierry Langer
March 2017, Journal of chemical information and modeling,
Gerhard Wolber, and Thomas Seidel, and Fabian Bendix, and Thierry Langer
September 2022, Chemical biology & drug design,
Gerhard Wolber, and Thomas Seidel, and Fabian Bendix, and Thierry Langer
February 2014, Journal of structural biology,
Copied contents to your clipboard!